recombinant interleukin-2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for recombinant interleukin-2, covering 2011-04-25 to 2011-04-25. Get the full timeline:
Most recent: Clinical Trial Update: An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy [Phase 3]